The Family Firm’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $551K | Hold |
|
|||||
|
2024
Q4 | $612K | Buy |
|
|||||
|
2024
Q3 | $648K | Buy |
|
|||||
|
2024
Q2 | $608K | Buy |
|
|||||
|
2024
Q1 | $621K | Sell |
|
|||||
|
2023
Q4 | $604K | Buy |
|
|||||
|
2023
Q3 | $480K | Buy |
|
|||||
|
2023
Q2 | $479K | Buy |
|
|||||
|
2023
Q1 | $375K | Sell |
|
|||||
|
2022
Q4 | $418K | Buy |
|
|||||
|
2022
Q3 | $361K | Hold |
|
|||||
|
2022
Q2 | $338K | Buy |
|